¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Polymorphism, Single Nucleotide"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • single nucleotide polymorphism
    ´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • polymorphism
    ´ÙÇüÅÂ, ¹µÇüÅÂ, ¿©·¯ÇüÅÂ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
  • multitarget single hit model
    ´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
  • single atrium
    Ȭ½É¹æ, ´Ü½É¹æ
  • single blind study
    ´ÜÀϸͰ˿¬±¸
  • single burst
    ÀÏȸ¹æÃâ·®
  • single colony isolation
    ´ÜÀÏÁý¶ôºÐ¸®, Áý¶ô°í¸£±â
  • single donor platelet
    ÀÏÀÎÇåÇ÷ÀÚÇ÷¼ÒÆÇ, ÀÏÀΰøÇ÷ÀÚÇ÷¼ÒÆÇ
  • single immunodiffusion
    ´ÜÀϸ鿪Ȯ»ê
  • single injection technique
    ÀÏȸÁÖÀÔ¹ý
  • single interference pattern
    ´ÜÀϰ£¼·¾ç»ó
  • single investing method
    ÀÏȸ¸Å¸ô¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • polymorphism
    ´ÙÇüÅÂ, ¿©·¯ÇüÅÂÁõ
  • single blinding study
    ´Ü¼ø¸Í°Ë¹ý
  • single vision
    ´ÜÀϽÃ
  • single ventricle
    ´Ü½É½Ç, Ȭ½É½Ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymorphism
    ´ÙÇüÅÂ, ¿©·¯ÇüÅÂÁõ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • complementary nucleotide
    »óº¸´ºÅ¬·¹¿ÀƼµå
  • diphosphopyridine nucleotide
    ÀÌÀλêÇǸ®µò´ºÅ¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀƼµå
  • single atrium
    Ȭ½É¹æ, ´Ü½É¹æ
  • single burst
    ÀÏȸ¹æÃâ·®
  • single-agent chemotherapy
    ´ÜÀÏÁ¦Á¦Ç×¾ÏÈ­Çпä¹ý
  • single-step growth curve
    ÀÏȸÁõ½Ä°î¼±
  • single fiber electrode
    ´ÜÀϼ¶À¯Àü±Ø
  • single outlet heart
    ´ÜÀÏÀ¯Ãâ·Î½ÉÀå
  • single immunodiffusion
    ´ÜÀϸ鿪Ȯ»ê
  • single colony isolation
    ´ÜÀÏÁý¶ôºÐ¸®, Áý¶ô°í¸£±â
  • single linkage
    ´ÜÀÏ¿¬¼â
  • multitarget single hit model
    ´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SPECT, see single positron emission computed tomopraphy
    ½ºÆåÆ®(´ÜÀϾçÀÚ¹æÃâÀü»êÈ­´ÜÃþÃÔ¿µ¼ú)
  • growth curve, single-step
    ÀÏȸÁõ½Ä°î¼±
  • DNA polymorphism
    DNA ´ÙÇü¼º
  • polymorphism
    ´ÙÇüÁõ
  • polymorphism
    ´ÙÇüÁõ(Òýû¡à÷ñø)
  • polymorphism
    ´ÙÇü¼ºÁõ
  • polymorphism
    ´ÙÇü, ´ÙÇüÅÂ
  • polymorphism
    ´ÙÇü¼º(Òýû¡à÷), ´ÙÇüÇö»ó(Òýû¡úÞßÚ)
  • polymorphism
    ´ÙÇü¼º(Òýúþàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphosphopyridine nucleotide =DPN
    ÀÌÀλêÇǸ®µò ´©Å¬·¹¿ÀƼµå.
  • nicotinamide adenine nucleotide
    ´ÏÄÚÆ¾¾Æ¹Ìµå¾Æµ¥´Ñ´©Å¬·¹¿ÀƼµå
  • nucleotide
    ´ºÅ¬·¹¿ÀŸÀ̵å
  • nucleotide
    ´©Å¬¸®¿ÀŸÀÌ.
  • triphosphopyridine nucleotide
    »ïÀλêÇǸ®µò´©Å¬·¹¿ÀƼµå.
  • pharmacogenetic polymorphism
    ¾à¹°À¯ÀüÇÐÀû ´ÙÇü¼º.
  • polymorphism
    ´ÙÇü, ´ÙÇüÅÂ
  • polymorphism
    ´ÙÇü¼º(Òýû¡à÷), ´ÙÇüÇö»ó(Òýû¡úÞßÚ)
  • polymorphism
    ´ÙÇü¼º(Òýúþàõ)
  • polymorphism
    ´ÙÇüÁõ
  • polymorphism
    ´ÙÇüÁõ(Òýû¡à÷ñø)
  • polymorphism
    ´ÙÇü¼ºÁõ
  • restriction fragment length polymorphism
    Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡­Òýû¡à÷)
  • restriction fragment length polymorphism,in cystic fibrosis
    ³¶¼º¼¶À¯Áõ(ÀÇ)¡­(Ò¥àõàéë«ñø¡­)
  • restriction fragment length polymorphism analysis
    Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á